Sucampo Pharmaceuticals hires de Santis as VP
August 26, 2008
BETHESDA, MD: Sucampo Pharmaceuticals, a biopharma company based in Bethesda, MD, named Kathryn de Santis as VP, investor relations and corporate communications, effective August 25. She previously held the position of director of IR and corporate communications at Rockville, MD-based Human Genome Sciences for 11 years. The position at Sucampo was vacant for four months.
BETHESDA, MD: Sucampo Pharmaceuticals, a biopharma company based in Bethesda, MD, named Kathryn de Santis as VP, investor relations and corporate communications, effective August 25. She previously held the position of director of IR and corporate communications at Rockville, MD-based Human Genome Sciences for 11 years. The position at Sucampo was vacant for four months.
Have you registered with us yet?
Register now to enjoy more articles and free email bulletins
Register
Already registered?
Sign in
